DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tasigna (Nilotinib) - News

 
 



News related to Tasigna (Nilotinib) and/or conditions it is approved for

Health Canada approves IMBRUVICA for chronic lymphocytic leukemia
Source: Cancer / Oncology News From Medical News Today [2014.11.20]
Janssen Inc. has announced Health Canada has approved IMBRUVICA (ibrutinib) for the treatment of the blood cancer chronic lymphocytic leukemia (CLL).

Anti-leukemia drug may also work against ovarian cancer
Source: Immune System / Vaccines News From Medical News Today [2014.11.20]
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer - and likely other cancers as well, report researchers at...

Researchers discover new way to fight chronic myeloid leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.19]
Chronic myeloid leukemia develops when a gene mutates and causes an enzyme to become hyperactive, causing blood-forming stem cells in the bone marrow to grow rapidly into abnormal cells.

IU researchers identify key mechanism and potential target to prevent leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.17]
Researchers have identified two proteins that appear crucial to the development - and patient relapse - of acute myeloid leukemia.

Actimab-A Phase I/II trial interim data demonstrate extension of overall survival to 9.1 months in elderly secondary acute myeloid leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.11]
Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced positive interim data...

"Smart bomb" engineered by researchers to attack childhood leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.07]
Fatih Uckun, Jianjun Cheng and their colleagues have taken the first steps towards developing a so-called "smart bomb" to attack the most common and deadly form of childhood cancer - called B-lineage...

New classification improves risk prediction in chronic lymphocytic leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.04]
If chronic lymphocytic leukemia patients with a good or poor prognosis could be identified already at the time of diagnosis, physicians would have better possibilities to adjust their therapeutic...

ATIR™ granted orphan drug designation by EMA for the treatment of acute myeloid leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.03]
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today announces that its lead product ATIR(TM) has been granted Orphan...

Air pollution link between childhood leukemia and power lines being questioned
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.03]
Researchers from the UK have called into question a theory suggesting that a previously reported risk of leukaemia among children born close to overhead power lines could be caused by an alteration...

UF researchers discover leukemia's hiding places
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.29]
In patients with leukemia, cancer cells can embed within the walls of blood vessels and hide from chemotherapy, according to a University of Florida study published in the journal Leukemia.

Obese Children With Leukemia Fared Worse in Study
Source: MedicineNet Leukemia Specialty [2014.10.28]
Title: Obese Children With Leukemia Fared Worse in Study
Category: Health News
Created: 10/27/2014 12:00:00 AM
Last Editorial Review: 10/28/2014 12:00:00 AM

New study may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.23]
Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia.

Many older people have mutations linked to leukemia, lymphoma in their blood cells
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.21]
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University...

Personalized cellular therapy achieves complete remission in 90 percent of acute lymphoblastic leukemia patients studied
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.20]
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an...

CNIO researchers associate 2 oncogenes with the aggressiveness and incidence of leukemia in mice
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.10.14]
Proteins regulating cell division determine tumour growth. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of cancer...

Hospital Admission Day Tied to Outcomes for Children With Leukemia
Source: MedicineNet Leukemia Specialty [2014.08.26]
Title: Hospital Admission Day Tied to Outcomes for Children With Leukemia
Category: Health News
Created: 8/25/2014 4:35:00 PM
Last Editorial Review: 8/26/2014 12:00:00 AM

Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Source: Compliance News From Medical News Today [2014.06.04]
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse...

Leukemia
Source: MedicineNet Carpal Tunnel Syndrome Specialty [2014.03.14]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/14/2014 12:00:00 AM

New Drug Combo Might Help Older, Sicker Patients With Leukemia
Source: MedicineNet rituximab Specialty [2014.01.10]
Title: New Drug Combo Might Help Older, Sicker Patients With Leukemia
Category: Health News
Created: 1/9/2014 2:35:00 PM
Last Editorial Review: 1/10/2014 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

In pediatric umbilical cord transplants, survival rates may indicate a new standard of care
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.11.03]
A new standard of care for children facing acute myeloid leukemia (AML) may be clear, following a multi-year study published in the latest edition of the New England Journal of Medicine.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014